Paul Baehr
Amministratore Delegato presso IBEX TECHNOLOGIES
Profilo
Paul Baehr's current job(s) include being the Chairman, President & Chief Executive Officer at IBEX Technologies, Inc., the President & Chief Executive Officer at Bio-Research Products, Inc., and a Director at NeuroMedix, Inc. Mr. Baehr's former job(s) include being a Director at Haemacure Corp.
from 1998 to 2013, a Director at Transition Therapeutics, Inc., a Director at National Pharmaceutical Council, a Director at St. Barnabas Hospital, a Director at Acurx Pharmaceuticals, Inc., a Senior Vice President at Ciba-Geigy Corp.
from 1980 to 1984, a Vice President-Pharmaceuticals at Eastman Kodak Co., a GM-Canadian Pharmaceuticals Division at Novartis AG, a Senior Vice President at Ciba-Geigy AG, an Executive Vice President at Sterling Winthrop, Inc., an Executive Vice President at Sterling Winthrop Pharmaceuticals Research Center, and the President at Ciba-Geigy Canada Ltd.
from 1979 to 1980.
Mr. Baehr's education history includes completing his undergraduate degree at the University of British Columbia.
Posizioni attive di Paul Baehr
| Società | Posizione | Inizio |
|---|---|---|
| IBEX TECHNOLOGIES | Amministratore Delegato | - |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | - |
Bio-Research Products, Inc.
 Bio-Research Products, Inc. BiotechnologyHealth Technology Bio-Research Products, Inc. manufactures enzymes for biomedical manufacturing and research. It specializes in protein purification, characterization and analysis. The company was founded in 1975 and is headquartered in North Liberty, IA. | Amministratore Delegato | - |
Precedenti posizioni note di Paul Baehr
| Società | Posizione | Fine |
|---|---|---|
Haemacure Corp.
 Haemacure Corp. Industrial SpecialtiesProcess Industries Haemacure Corp. is engaged in the development, marketing and sales of surgical sealants and related medical devices. Its primary product is a fibrin sealant, a tissue sealant comprised of fibrinogen and thrombin extracted from human plasma. The fibrin sealant is used in surgical procedures to arrest bleeding and as an adjunct to wound healing. It was founded on August 19, 1991 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | 06/09/2013 |
| Ciba-Geigy Corp. | Corporate Officer/Principal | 01/12/1984 |
| Ciba-Geigy Canada Ltd. | Presidente | 01/09/1980 |
| Sterling Winthrop Pharmaceuticals Research Center | Corporate Officer/Principal | - |
| ACURX PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - |
Formazione di Paul Baehr
| University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| EASTMAN KODAK COMPANY | Producer Manufacturing |
| NOVARTIS AG | Health Technology |
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 12 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
Haemacure Corp.
Haemacure Corp. Industrial SpecialtiesProcess Industries Haemacure Corp. is engaged in the development, marketing and sales of surgical sealants and related medical devices. Its primary product is a fibrin sealant, a tissue sealant comprised of fibrinogen and thrombin extracted from human plasma. The fibrin sealant is used in surgical procedures to arrest bleeding and as an adjunct to wound healing. It was founded on August 19, 1991 and is headquartered in Montreal, Canada. | Process Industries |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
IBEX Technologies, Inc.
 IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Sterling Winthrop, Inc.
 Sterling Winthrop, Inc. Electronics/AppliancesConsumer Durables Part of GSK Plc, Sterling Winthrop, Inc. is a private company that specializes in cameras and duplicating machines. The company is based in Rochester, NY. Sterling Winthrop was acquired by GSK Plc from Eastman Kodak Co. on November 03, 1994 for $2,930 million. | Consumer Durables |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
| Sterling Winthrop Pharmaceuticals Research Center | |
St. Barnabas Hospital
 St. Barnabas Hospital Hospital/Nursing ManagementHealth Services St. Barnabas Hospital provides health care services. It provides various medical services in the areas of allergy and immunology, cardiology, diabetes and endocrine disorders, family practice, gastroenterology and hepatology, geriatrics, hematology and infectious diseases. The company was founded on April 06, 1866 and is headquartered in Bronx, Ny. | Health Services |
Bio-Research Products, Inc.
Bio-Research Products, Inc. BiotechnologyHealth Technology Bio-Research Products, Inc. manufactures enzymes for biomedical manufacturing and research. It specializes in protein purification, characterization and analysis. The company was founded in 1975 and is headquartered in North Liberty, IA. | Health Technology |
| Ciba-Geigy Canada Ltd. |
- Borsa valori
- Insiders
- Paul Baehr
